301 related articles for article (PubMed ID: 25416666)
1. Pathophysiology of resistant hypertension in chronic kidney disease.
Campese VM
Semin Nephrol; 2014; 34(5):571-6. PubMed ID: 25416666
[TBL] [Abstract][Full Text] [Related]
2. Resistant hypertension: is renal denervation the current treatment of choice?
Reddi AS
Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
[TBL] [Abstract][Full Text] [Related]
3. Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome?
Vemulapalli S; Tyson CC; Svetkey LP
Adv Chronic Kidney Dis; 2014 Nov; 21(6):489-99. PubMed ID: 25443574
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
Hering D; Esler MD; Schlaich MP
EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
[TBL] [Abstract][Full Text] [Related]
5. Hypertension in Chronic Kidney Disease.
Hamrahian SM; Falkner B
Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
[TBL] [Abstract][Full Text] [Related]
6. Renal denervation for resistant hypertension.
Almeida Mde S; Gonçalves Pde A; Oliveira EI; Carvalho HC
Rev Port Cardiol; 2015 Feb; 34(2):125-35. PubMed ID: 25662472
[TBL] [Abstract][Full Text] [Related]
7. Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.
McArdle MJ; deGoma EM; Cohen DL; Townsend RR; Wilensky RL; Giri J
J Am Heart Assoc; 2015 Mar; 4(3):e001415. PubMed ID: 25801757
[No Abstract] [Full Text] [Related]
8. Obesity and insulin resistance in resistant hypertension: implications for the kidney.
Rao A; Pandya V; Whaley-Connell A
Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470
[TBL] [Abstract][Full Text] [Related]
9. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
Kjeldsen SE; Os I; Mahfoud F
EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
[No Abstract] [Full Text] [Related]
10. Pathogenesis of drug-resistant hypertension.
Townsend RR
Semin Nephrol; 2014; 34(5):506-13. PubMed ID: 25416659
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?
de Beus E; de Jager R; Joles JA; Grassi G; Blankestijn PJ
J Hypertens; 2014 Sep; 32(9):1751-61. PubMed ID: 24805954
[TBL] [Abstract][Full Text] [Related]
12. Expanding the indication spectrum: renal denervation in diabetes.
Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
[TBL] [Abstract][Full Text] [Related]
13. Renal denervation: current implications and future perspectives.
Xu J; Hering D; Sata Y; Walton A; Krum H; Esler MD; Schlaich MP
Clin Sci (Lond); 2014 Jan; 126(1):41-53. PubMed ID: 24020446
[TBL] [Abstract][Full Text] [Related]
14. Estimated GFR or albuminuria: which one is really associated with resistant hypertension?
Romero CA; Peixoto AJ; Orias M
Semin Nephrol; 2014; 34(5):492-7. PubMed ID: 25416657
[TBL] [Abstract][Full Text] [Related]
15. Renal nerve ablation for hypertensive patients with chronic kidney disease.
Papademetriou V; Doumas M; Anyfanti P; Faselis C; Kokkinos P; Tsioufis C
Curr Vasc Pharmacol; 2014 Jan; 12(1):47-54. PubMed ID: 23905594
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.
Ammar S; Ladich E; Steigerwald K; Deisenhofer I; Joner M
EuroIntervention; 2013 May; 9 Suppl R():R89-95. PubMed ID: 23732162
[TBL] [Abstract][Full Text] [Related]
17. Renal denervation: a plea for wisdom.
Lantelme P; Courand PY; Pathak A
Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
[No Abstract] [Full Text] [Related]
18. Role of sodium restriction and diuretic therapy for "resistant" hypertension in chronic kidney disease.
Sinnakirouchenan R; Kotchen TA
Semin Nephrol; 2014; 34(5):514-9. PubMed ID: 25416660
[TBL] [Abstract][Full Text] [Related]
19. Potential new indications and future studies.
Sudano I; Noll G; Luscher TF
EuroIntervention; 2013 May; 9 Suppl R():R155-60. PubMed ID: 23732149
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic activation in resistant hypertension: theory and therapy.
Oliva RV; Bakris GL
Semin Nephrol; 2014; 34(5):550-9. PubMed ID: 25416664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
